Author Title [ Type(Desc)] Year
Filters: Author is Li, Yun  [Clear All Filters]
Journal Article
Yu X, Wang Y, Deng M, Li Y, Ruhn KA, Zhang CCheng, Hooper LV. The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife. 2014;3.
Muffat J, Li Y, Jaenisch R. CNS disease models with human pluripotent stem cells in the CRISPR age. Curr Opin Cell Biol. 2016;43:96-103.
Muffat J, Li Y, Yuan B, Mitalipova M, Omer A, Corcoran S, Bakiasi G, Tsai L-H, Aubourg P, Ransohoff RM, et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat Med. 2016.
Hou C, Liu W, Xie L, Zheng J, Chen X, Sun X, Zhang Y, Xu M, Li Y, Xiao T. Generation of an induced pluripotent stem cell line from a Chinese Han child with arrhythmia. Stem Cell Res. 2021;51:102183.
Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway. Mol Cell Endocrinol. 2020:110921.
Rosen JD, Yang Y, Abnousi A, Chen J, Song M, Jones IR, Shen Y, Hu M, Li Y. HPRep: Quantifying Reproducibility in HiChIP and PLAC-Seq Datasets. Curr Issues Mol Biol. 2021;43(2):1156-1170.
Yang X, Bergenholtz S, Maliskova L, Pebworth M-P, Kriegstein AR, Li Y, Shen Y. SMART-Q:  An Integrative Pipeline Quantifying Cell Type-Specific RNA Transcription. PLoS One. 2020;15(4):e0228760.
Chen J, Huang S, Li H, Li Y, Zeng H, Hu J, Lin Y, Cai H, Deng P, Song T, et al. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration. Clin Transl Oncol. 2022.
Wen J, Lagler TM, Sun Q, Yang Y, Chen J, Harigaya Y, Sankaran VG, Hu M, Reiner AP, Raffield LM, et al. Super interactive promoters provide insight into cell type-specific regulatory networks in blood lineage cell types. PLoS Genet. 2022;18(1):e1009984.